GlassScriptPhysician profile
Terry L Burns
NPI 1801908108
$519.01
in general payments reported to CMS, 2019-2025
10 companies · $30.34 in 2025
The $30.34 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $109 · 2021: $49.16 · 2022: $126 · 2023: $21.32 · 2024: $66.83 · 2025: $30.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $118.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $146.80 | 2019-2025 | |
| Astellas Pharma US INC | $128.52 | 2019-2022 | |
| Amgen INC. | $71.11 | 2019-2020 | |
| Pfizer INC. | $57.51 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $42.75 | 2023-2024 | Farxiga |
| Exact Sciences Corporation | $18.19 | 2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $15.67 | 2025 | |
| Dexcom, INC. | $13.84 | 2024 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $13.37 | 2024 | Gemtesa |
| Sunovion Pharmaceuticals INC. | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.